Fexofenadine Hydrochloride

盐酸非索非那定

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameFexofenadine Hydrochloride
Drug Alias Name盐酸非索钠汀fexofenadinumfexofenadina非索非那定盐酸盐Raltiva +[15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsEdemaChronic UrticariaPruritus +[13
Global Approved IndicationsChronic UrticariaPruritusEczema +[6
Approved Indications in ChinaChronic UrticariaRhinitis, Allergic, Seasonal
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1996/03/11
Country/TerritoryCanadaUnited StatesPoland +[13
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active IndicationsChronic UrticariaPruritusEczema +[10
Inactive IndicationsEdemaAsthmaGastroesophageal Reflux

Other Information

ATC CodeR06AX26